Synthomer (SYNT): Cost savings programme
This situation live
SYNT Synthomer
23 Oct 2025 · Largely completed; on track · −4% until the next step
has now largely been completed and is on track to deliver c.£20-25m in savings on an annual run-rate basis by 2026.
29 Jan 2026 · Expanded programmes delivering; 2026 full-year benefit · −52% until the next step
The continued focus on strong operational execution, together with expanded 'self-help' cost reduction programmes, have enabled us to mitigate the impact of softer end-market demand since global tarif
19 Mar 2026 · Self-help actions driving 2026 progress · +165% until the next step
The Company continues to focus on delivering further year-on-year progress in 2026 driven primarily by its self-help actions.
30 Apr 2026 · £30m delivered in 2025; more to come in 2026 · +44% until the next step
Taken together, our operating cost reduction programmes are expected to deliver c.£ 20-25m in incremental gross benefits in 2026.
4 Aug 2026 · c.£13m delivered in H1 2026 · +14% since
Meanwhile, we have continued our rigorous focus on cost management, delivering c.£13m in benefits on a year-on-year run-rate basis in H1 2026, having achieved c.£30m in 2025.
Cost savings programme
c.£13m delivered in H1 2026
Next: H2 delivery of the c.£20-25m 2026 savings target
Every step · 5
- 23 Oct 2025 Largely completed; on track – has now largely been completed and is on track to deliver c.£20-25m in savings on an annual run-rate basis by 2026. ↗
- 29 Jan 2026 Expanded programmes delivering; 2026 full-year benefit – The continued focus on strong operational execution, together with expanded 'self-help' cost reduction programmes, have enabled us to mitigate the impact of... ↗
- 19 Mar 2026 Self-help actions driving 2026 progress – The Company continues to focus on delivering further year-on-year progress in 2026 driven primarily by its self-help actions. ↗
- 30 Apr 2026 £30m delivered in 2025; more to come in 2026 – Taken together, our operating cost reduction programmes are expected to deliver c.£ 20-25m in incremental gross benefits in 2026. ↗
- 4 Aug 2026 c.£13m delivered in H1 2026 – Meanwhile, we have continued our rigorous focus on cost management, delivering c.£13m in benefits on a year-on-year run-rate basis in H1 2026, having... ↗
What is happening
Synthomer: Cost savings programme – c.£13m delivered in H1 2026. ['c.£13m delivered in H1 2026']
- In short
- Self-help cost programme since Oct 2025. £30m of benefit was delivered in 2025, with a further c.£20-25m gross expected in 2026 after about 250 role removals. The H1 2026 interims report c.£13m of year-on-year run-rate benefits, so the programme is on track. Savings help support the £8m of underlying H1 EBITDA progress.
- Announced
- 23 Oct 2025 · Largely completed; on track
- Latest
- 4 Aug 2026 · c.£13m delivered in H1 2026
- 2025 delivered
- c.£30m self-help benefits
- 2026 target
- c.£20-25m incremental gross benefits
- Headcount
- Around 250 roles removed in H2 2025
- Margin effect
- Gross margin +200bps; EBITDA margin +40bps to 7.8%
- H1 2026 delivered
- c.£13m year-on-year run-rate benefits
What comes next
H2 delivery of the c.£20-25m 2026 savings target.
Briefing Pro
New to Synthomer? Get up to speed in 2 minutes.
What it does, how it got here, what management promised and delivered – written from its own announcements.
Get the SYNT briefing →From the company's own announcements. Not investment advice.
Also at Synthomer 1 open
Disposal of a part (break-up)Broadened divestment programme – Acrylate Monomers sale completed; three processes continue
Balance-sheet stress / refinancingDebt refinancing and possible capital raise – Refinanced to 2029; covenants reset · closed
Insider conviction1 director buying – £31k in 1 buy · closed
Insider conviction4 directors buying – £87k in 4 buys · closed
Synthomer – company page →